Virtu Financial LLC Takes Position in Enovix Corporation $ENVX

Virtu Financial LLC bought a new position in Enovix Corporation (NASDAQ:ENVX) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 116,064 shares of the company’s stock, valued at approximately $848,000. Virtu Financial LLC owned approximately 0.05% of Enovix at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Jupiter Asset Management Ltd. acquired a new position in Enovix during the third quarter worth $2,465,000. Granahan Investment Management LLC lifted its holdings in shares of Enovix by 17.5% during the third quarter. Granahan Investment Management LLC now owns 1,749,649 shares of the company’s stock valued at $17,444,000 after acquiring an additional 260,085 shares during the period. DNB Asset Management AS boosted its stake in shares of Enovix by 378.6% in the 3rd quarter. DNB Asset Management AS now owns 210,748 shares of the company’s stock valued at $2,101,000 after purchasing an additional 166,712 shares in the last quarter. Fred Alger Management LLC boosted its stake in shares of Enovix by 9.4% in the 3rd quarter. Fred Alger Management LLC now owns 1,442,986 shares of the company’s stock valued at $14,387,000 after purchasing an additional 123,814 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Enovix by 1.1% in the 3rd quarter. Vanguard Group Inc. now owns 16,013,563 shares of the company’s stock worth $159,655,000 after purchasing an additional 175,599 shares during the last quarter. Institutional investors own 50.92% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on ENVX shares. Canaccord Genuity Group dropped their target price on shares of Enovix from $21.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Wells Fargo & Company set a $6.00 target price on shares of Enovix in a research note on Thursday, March 12th. Bank of America assumed coverage on shares of Enovix in a research report on Thursday, March 12th. They set a “neutral” rating and a $6.00 price target for the company. Weiss Ratings restated a “sell (e+)” rating on shares of Enovix in a report on Friday, April 10th. Finally, Benchmark cut their price objective on shares of Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Seven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Enovix has an average rating of “Moderate Buy” and an average price target of $12.64.

Enovix Stock Performance

NASDAQ:ENVX opened at $7.08 on Monday. Enovix Corporation has a 1-year low of $4.61 and a 1-year high of $16.49. The business’s 50-day moving average price is $6.81 and its two-hundred day moving average price is $6.73. The company has a current ratio of 10.97, a quick ratio of 10.65 and a debt-to-equity ratio of 2.14. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of -8.53 and a beta of 2.27.

Enovix (NASDAQ:ENVX) last posted its earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.01. The company had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.95 million. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The company’s revenue for the quarter was up 49.1% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.15) EPS. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, equities analysts expect that Enovix Corporation will post -0.79 earnings per share for the current year.

Enovix Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.